Fauske L, Bruland ØS, Holtermann A, Larsen SG(2026) Experiences and Hopes Among Patients with Colorectal Carcinoma and Peritoneal Metastases Who Are Participating in an Early-Phase Clinical Trial Cancers (Basel), 18(2) DOI 10.3390/cancers18020244, PubMed 41595164
Kristiansen SK, Shubin K, Zubrienė A, Matulis D, Dernjani N, Juzenas P, Bruland ØS, Juzeniene A(2026) Radiobiological investigations of a [212Pb]Pb-carbonic anhydrase IX-targeting small-molecule ligand in renal cell carcinoma and colorectal cancer models Int J Radiat Biol, 102(2), 127-137 DOI 10.1080/09553002.2025.2595630, PubMed 41481374
Berner K, Hernes E, Kvassheim M, Revheim ME, Bastiansen J, Selboe S, Bakken CL, Grønningsæter SR, Bruland ØS, Larsen RH, Bouzelmat L, Jardine VL, Stokke C(2025) First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer J Nucl Med, 66(5), 732-738 DOI 10.2967/jnumed.124.269299, PubMed 40081958
